Association between sleep apnea syndrome and hypertension/endocrine disorders

Association between sleep apnea syndrome and hypertension/endocrine disorders - SAS-HTN/Endo study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009301

Enrollment

100

Registered

2012-11-11

Start date

2012-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea syndrome, hypertension, metabolic syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with insomnia, apnea, hypertension, or obesity-related diseases etc.

Exclusion criteria

Exclusion criteria: patients with renal dysfunction (Cr>or=3.0)

Design outcomes

Primary

Measure	Time frame
blood pressure after therapy for sleep apnea syndrome (nCPAP)	—

Secondary

Measure	Time frame
Parameters for sleep disorders including AHI, parameters for metabolic disorders including BMI, plasma glucose, and continuous glucose monitoring, parameters for endocrine disorders including plasma/urinary aldosterone and catecholamines etc.	—

Countries

Japan

Outcome results